Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still’s Disease

Table 1

Laboratory findings.

Peripheral blood		Serological tests
Red blood cells	406 × 10^4/μL	C-reactive protein	<0.30 mg/dL
Hemoglobin	10.5 g/dL	Erythrocyte sedimentation rate	3.0 mm/hr
White blood cells	9600/μL	IgG	883 mg/dL (900–2000)
St	23.0%	Ferritin	613 ng/mL (10–85)
Seg	66.0%	C3	108 mg/dL (4–64)
Ly	6.0%	C4	24 mg/dL (17–45)
Mo	4.0%	CH50	42.7 U/mL (30–50)
AtyLy	1.0%	Anti-nuclear Ab	<×40
Platelet	12.1 × 10^4/μL	Anti-CCP Ab	<0.6 U/mL (<4.5)
Blood chemistry		β-D-glucan	(−)
Total protein	5.9 g/dL
Albumin	3.9 g/dL	CSF
Total bilirubin	0.6 mg/dL	Cell number	55/mm^3
Glutamic-oxaloacetic transaminase	176 IU/L (7–33)	Neutrophils	3%
Glutamic-pyruvic transaminase	181 IU/L (5–30)	Monocytes	97%
Lactate dehydrogenase	518 IU/L (260–480)
Alkaline phosphatase	271 IU/L (80–250)	Protein	92 mg/dL
Creatinine kinase	21 IU/L (60–160)	Sugar	45 mg/dL
Total cholesterol	217 mg/dL	Cl	103 mEq/L
Blood urea nitrogen	10.8 mg/dL	Herpes zoster DNA (PCR method)	(+)
Creatinine	0.4 mg/dL
Na	128 mEq/L
K	3.5 mEq/L
Cl	95 mEq/L

Anti-CCP Ab, anti-cyclic citrullinated peptide antibody; CSF, cerebrospinal fluid; PCR, polymerase chain reaction.